Serenio, Helen P.

HRN: 03-44-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/10/2026
04/17/2026
IV
600mg
Q8
Fracture, Multiple Lacerated Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: